1. Home
  2. CMRE vs COLL Comparison

CMRE vs COLL Comparison

Compare CMRE & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Costamare Inc. $0.0001 par value

CMRE

Costamare Inc. $0.0001 par value

N/A

Current Price

$16.80

Market Cap

1.8B

ML Signal

N/A

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

N/A

Current Price

$35.53

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CMRE
COLL
Founded
1974
2002
Country
Monaco
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.2B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CMRE
COLL
Price
$16.80
$35.53
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$12.00
$50.83
AVG Volume (30 Days)
428.7K
392.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.70%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.73
Revenue
N/A
$780,567,000.00
Revenue This Year
N/A
$6.07
Revenue Next Year
N/A
N/A
P/E Ratio
$5.55
$21.14
Revenue Growth
N/A
23.62
52 Week Low
$6.63
$23.23
52 Week High
$17.91
$50.79

Technical Indicators

Market Signals
Indicator
CMRE
COLL
Relative Strength Index (RSI) 48.68 18.21
Support Level $15.21 $34.30
Resistance Level $17.64 $36.20
Average True Range (ATR) 0.57 1.59
MACD -0.08 -0.77
Stochastic Oscillator 37.16 0.87

Price Performance

Historical Comparison
CMRE
COLL

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: